Related Experiment Video
Updated: Jul 20, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Hyperglycemia and morbidity and mortality in extremely low birth weight infants
L S Kao1, B H Morris, K P Lally
1Department of Surgery, Lyndon Baines Johnson General Hospital, University of Texas, Houston Medical School, Houston, TX 77026, USA. Lillian.S.Kao@uth.tmc.edu
Insights
Severe hyperglycemia in extremely low birth weight (ELBW) infants within the first week of life is linked to higher mortality and sepsis risk. This finding highlights the importance of glucose management in high-risk newborns.
Area of Science:
- Neonatalogy
- Endocrinology
- Pediatric Critical Care
Background:
- Extremely low birth weight (ELBW) infants are a vulnerable population facing significant health challenges.
- Hyperglycemia is a common metabolic disturbance in ELBW infants, with unclear associations with adverse outcomes.
- Understanding the impact of hyperglycemia on mortality and infection is crucial for improving neonatal care.
Purpose of the Study:
- To investigate the association between hyperglycemia and mortality in ELBW infants.
- To determine the relationship between hyperglycemia and late-onset infections (>72 hours) in ELBW infants.
- To explore hyperglycemia's link with necrotizing enterocolitis in this population.
Main Methods:
- Retrospective analysis of a prospective cohort of 201 ELBW infants surviving >3 days.
- Categorization of mean morning glucose levels into normoglycemia, mild-moderate hyperglycemia, and severe hyperglycemia.
- Logistic regression used to assess associations between early/persistent hyperglycemia and mortality/infection.
Main Results:
- Severe early and persistent hyperglycemia were significantly associated with increased mortality in ELBW infants.
- Severe hyperglycemia was linked to a higher odds ratio for death or late-onset infection.
- Persistent severe hyperglycemia was associated with a higher risk of developing Stage II/III necrotizing enterocolitis.
Conclusions:
- Severe hyperglycemia in the initial days of life is a significant risk factor for mortality and sepsis in ELBW infants.
- Glucose control in the early neonatal period is critical for improving outcomes in ELBW infants.
- Further research may elucidate specific mechanisms linking hyperglycemia to adverse events in ELBW neonates.
Objective:
The purpose of this study was to determine the association between hyperglycemia and mortality and late-onset infections (>72 h) in extremely low birth weight (ELBW) infants.
Study Design:
Retrospective analysis of a prospective cohort study of 201 ELBW infants who survived greater than 3 days after birth. Mean morning glucose levels were categorized as normoglycemia (<120 mg/dl), mild-moderate hyperglycemia (120 to 179 mg/dl) and severe hyperglycemia (> or =180 mg/dl). Hyperglycemia was further divided into early (first 3 days of age) and persistent (first week of age). Logistic regression was performed to assess whether hyperglycemia was associated with either mortality or late-onset culture-proven infection, measured after 3 and 7 days of age.
Results:
Adjusting for age, the odds ratio (OR) for either dying or developing a late infection was 5.07 (95% confidence interval (CI): 1.06 to 24.3) for infants with early severe hyperglycemia and 6.26 (95% CI: 0.73 to 54.0) for infants with persistent severe hyperglycemia. Adjusting for age, both severe early and persistent hyperglycemia were associated with increased mortality. Among survivors, there was no significant association between hyperglycemia and length of mechanical ventilation or length of hospital stay. Persistent severe hyperglycemia was associated with the development of Stage II/III necrotizing enterocolitis, after adjusting for age and male gender (OR: 9.49, 95% CI: 1.52 to 59.3).
Conclusion:
Severe hyperglycemia in the first few days after birth is associated with increased odds of death and sepsis in ELBW infants.
Related Concept Videos
Hypoglycemia
Hyperglycemia
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational
Hypoglycemia and Glucagon
Type I Diabetes III: Clinical Manifestations
